ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharmaceuticals for Psoriasis Market Research Report 2026
Published Date: 2026-03-20
|
Report Code: QYRE-Auto-13L17649
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceuticals for Psoriasis Market Research Report 2024
BUY CHAPTERS

Global Biopharmaceuticals for Psoriasis Market Research Report 2026

Code: QYRE-Auto-13L17649
Report
2026-03-20
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Eli Lilly
Johnson & Johnson
Pfizer Inc
AbbVie
Organon
UCB
Johnson & Johnson

Biopharmaceuticals for Psoriasis Market

The global Biopharmaceuticals for Psoriasis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Biopharmaceuticals for Psoriasis competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Psoriasis is a common chronic inflammatory skin disease characterized by excessive proliferation of skin cells, resulting in thick, red patches covered with silvery-white scales on the skin surface. The cause of psoriasis is not fully understood, but it is believed to be related to abnormalities in the immune system, especially excessive activity of T cells in the skin. Genetic factors and environmental factors (such as infection, stress, skin damage and certain drugs) may also induce or aggravate the disease.
The North American market for Biopharmaceuticals for Psoriasis is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Biopharmaceuticals for Psoriasis is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Biopharmaceuticals for Psoriasis include Amgen, Eli Lilly, Johnson & Johnson, Pfizer, AbbVie, Organon, UCB, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Biopharmaceuticals for Psoriasis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biopharmaceuticals for Psoriasis. The Biopharmaceuticals for Psoriasis market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Biopharmaceuticals for Psoriasis market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Biopharmaceuticals for Psoriasis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Biopharmaceuticals for Psoriasis Market Report

Report Metric Details
Report Name Biopharmaceuticals for Psoriasis Market
Segment by Type
  • TNF-α
  • Interleukin-17
  • Interleukin-23
  • Other
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Eli Lilly, Johnson & Johnson, Pfizer, AbbVie, Organon, UCB
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Biopharmaceuticals for Psoriasis manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Biopharmaceuticals for Psoriasis sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharmaceuticals for Psoriasis Market report?

Ans: The main players in the Biopharmaceuticals for Psoriasis Market are Amgen, Eli Lilly, Johnson & Johnson, Pfizer, AbbVie, Organon, UCB

What are the Application segmentation covered in the Biopharmaceuticals for Psoriasis Market report?

Ans: The Applications covered in the Biopharmaceuticals for Psoriasis Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Biopharmaceuticals for Psoriasis Market report?

Ans: The Types covered in the Biopharmaceuticals for Psoriasis Market report are TNF-α, Interleukin-17, Interleukin-23, Other

1 Biopharmaceuticals for Psoriasis Market Overview
1.1 Product Definition
1.2 Biopharmaceuticals for Psoriasis by Type
1.2.1 Global Biopharmaceuticals for Psoriasis Market Value by Type: 2025 vs 2032
1.2.2 TNF-α
1.2.3 Interleukin-17
1.2.4 Interleukin-23
1.2.5 Other
1.3 Biopharmaceuticals for Psoriasis by Application
1.3.1 Global Biopharmaceuticals for Psoriasis Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Biopharmaceuticals for Psoriasis Market Size Estimates and Forecasts
1.4.1 Global Biopharmaceuticals for Psoriasis Revenue 2021–2032
1.4.2 Global Biopharmaceuticals for Psoriasis Sales 2021–2032
1.4.3 Global Biopharmaceuticals for Psoriasis Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Biopharmaceuticals for Psoriasis Market Competition by Manufacturers
2.1 Global Biopharmaceuticals for Psoriasis Sales Market Share by Manufacturers (2021–2026)
2.2 Global Biopharmaceuticals for Psoriasis Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Biopharmaceuticals for Psoriasis Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Biopharmaceuticals for Psoriasis, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Product Types and Applications
2.7 Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Date of Entry into the Industry
2.8 Global Biopharmaceuticals for Psoriasis Market Competitive Situation and Trends
2.8.1 Global Biopharmaceuticals for Psoriasis Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Biopharmaceuticals for Psoriasis Players Market Share by Revenue
2.8.3 Global Biopharmaceuticals for Psoriasis Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biopharmaceuticals for Psoriasis Market Scenario by Region
3.1 Global Biopharmaceuticals for Psoriasis Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Biopharmaceuticals for Psoriasis Sales by Region: 2021–2032
3.2.1 Global Biopharmaceuticals for Psoriasis Sales by Region: 2021–2026
3.2.2 Global Biopharmaceuticals for Psoriasis Sales by Region: 2027–2032
3.3 Global Biopharmaceuticals for Psoriasis Revenue by Region: 2021–2032
3.3.1 Global Biopharmaceuticals for Psoriasis Revenue by Region: 2021–2026
3.3.2 Global Biopharmaceuticals for Psoriasis Revenue by Region: 2027–2032
3.4 North America Biopharmaceuticals for Psoriasis Market Facts & Figures by Country
3.4.1 North America Biopharmaceuticals for Psoriasis Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Biopharmaceuticals for Psoriasis Sales by Country (2021–2032)
3.4.3 North America Biopharmaceuticals for Psoriasis Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biopharmaceuticals for Psoriasis Market Facts & Figures by Country
3.5.1 Europe Biopharmaceuticals for Psoriasis Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Biopharmaceuticals for Psoriasis Sales by Country (2021–2032)
3.5.3 Europe Biopharmaceuticals for Psoriasis Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biopharmaceuticals for Psoriasis Market Facts & Figures by Region
3.6.1 Asia Pacific Biopharmaceuticals for Psoriasis Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Biopharmaceuticals for Psoriasis Sales by Region (2021–2032)
3.6.3 Asia Pacific Biopharmaceuticals for Psoriasis Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biopharmaceuticals for Psoriasis Market Facts & Figures by Country
3.7.1 Latin America Biopharmaceuticals for Psoriasis Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Biopharmaceuticals for Psoriasis Sales by Country (2021–2032)
3.7.3 Latin America Biopharmaceuticals for Psoriasis Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biopharmaceuticals for Psoriasis Market Facts & Figures by Country
3.8.1 Middle East and Africa Biopharmaceuticals for Psoriasis Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country (2021–2032)
3.8.3 Middle East and Africa Biopharmaceuticals for Psoriasis Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biopharmaceuticals for Psoriasis Sales by Type (2021–2032)
4.1.1 Global Biopharmaceuticals for Psoriasis Sales by Type (2021–2026)
4.1.2 Global Biopharmaceuticals for Psoriasis Sales by Type (2027–2032)
4.1.3 Global Biopharmaceuticals for Psoriasis Sales Market Share by Type (2021–2032)
4.2 Global Biopharmaceuticals for Psoriasis Revenue by Type (2021–2032)
4.2.1 Global Biopharmaceuticals for Psoriasis Revenue by Type (2021–2026)
4.2.2 Global Biopharmaceuticals for Psoriasis Revenue by Type (2027–2032)
4.2.3 Global Biopharmaceuticals for Psoriasis Revenue Market Share by Type (2021–2032)
4.3 Global Biopharmaceuticals for Psoriasis Price by Type (2021–2032)
5 Segment by Application
5.1 Global Biopharmaceuticals for Psoriasis Sales by Application (2021–2032)
5.1.1 Global Biopharmaceuticals for Psoriasis Sales by Application (2021–2026)
5.1.2 Global Biopharmaceuticals for Psoriasis Sales by Application (2027–2032)
5.1.3 Global Biopharmaceuticals for Psoriasis Sales Market Share by Application (2021–2032)
5.2 Global Biopharmaceuticals for Psoriasis Revenue by Application (2021–2032)
5.2.1 Global Biopharmaceuticals for Psoriasis Revenue by Application (2021–2026)
5.2.2 Global Biopharmaceuticals for Psoriasis Revenue by Application (2027–2032)
5.2.3 Global Biopharmaceuticals for Psoriasis Revenue Market Share by Application (2021–2032)
5.3 Global Biopharmaceuticals for Psoriasis Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Biopharmaceuticals for Psoriasis Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Amgen Biopharmaceuticals for Psoriasis Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Biopharmaceuticals for Psoriasis Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eli Lilly Biopharmaceuticals for Psoriasis Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Biopharmaceuticals for Psoriasis Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Johnson & Johnson Biopharmaceuticals for Psoriasis Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Biopharmaceuticals for Psoriasis Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Pfizer Biopharmaceuticals for Psoriasis Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Company Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Biopharmaceuticals for Psoriasis Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 AbbVie Biopharmaceuticals for Psoriasis Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Organon
6.6.1 Organon Company Information
6.6.2 Organon Description and Business Overview
6.6.3 Organon Biopharmaceuticals for Psoriasis Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Organon Biopharmaceuticals for Psoriasis Product Portfolio
6.6.5 Organon Recent Developments/Updates
6.7 UCB
6.7.1 UCB Company Information
6.7.2 UCB Description and Business Overview
6.7.3 UCB Biopharmaceuticals for Psoriasis Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 UCB Biopharmaceuticals for Psoriasis Product Portfolio
6.7.5 UCB Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biopharmaceuticals for Psoriasis Industry Chain Analysis
7.2 Biopharmaceuticals for Psoriasis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biopharmaceuticals for Psoriasis Production Mode & Process Analysis
7.4 Biopharmaceuticals for Psoriasis Sales and Marketing
7.4.1 Biopharmaceuticals for Psoriasis Sales Channels
7.4.2 Biopharmaceuticals for Psoriasis Distributors
7.5 Biopharmaceuticals for Psoriasis Customer Analysis
8 Biopharmaceuticals for Psoriasis Market Dynamics
8.1 Biopharmaceuticals for Psoriasis Industry Trends
8.2 Biopharmaceuticals for Psoriasis Market Drivers
8.3 Biopharmaceuticals for Psoriasis Market Challenges
8.4 Biopharmaceuticals for Psoriasis Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Eli Lilly
Johnson & Johnson
Pfizer Inc
AbbVie
Organon
UCB
Johnson & Johnson
List of Tables
 Table 1. Global Biopharmaceuticals for Psoriasis Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Biopharmaceuticals for Psoriasis Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Biopharmaceuticals for Psoriasis Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Biopharmaceuticals for Psoriasis Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Biopharmaceuticals for Psoriasis Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Biopharmaceuticals for Psoriasis Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Biopharmaceuticals for Psoriasis Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Biopharmaceuticals for Psoriasis, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Product Types and Applications
 Table 12. Global Key Manufacturers of Biopharmaceuticals for Psoriasis, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biopharmaceuticals for Psoriasis Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biopharmaceuticals for Psoriasis Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biopharmaceuticals for Psoriasis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Biopharmaceuticals for Psoriasis Sales by Region (K Units), 2021–2026
 Table 18. Global Biopharmaceuticals for Psoriasis Sales Market Share by Region (2021–2026)
 Table 19. Global Biopharmaceuticals for Psoriasis Sales by Region (K Units), 2027–2032
 Table 20. Global Biopharmaceuticals for Psoriasis Sales Market Share by Region (2027–2032)
 Table 21. Global Biopharmaceuticals for Psoriasis Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Region (2021–2026)
 Table 23. Global Biopharmaceuticals for Psoriasis Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Region (2027–2032)
 Table 25. North America Biopharmaceuticals for Psoriasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Biopharmaceuticals for Psoriasis Sales by Country (K Units), 2021–2026
 Table 27. North America Biopharmaceuticals for Psoriasis Sales by Country (K Units), 2027–2032
 Table 28. North America Biopharmaceuticals for Psoriasis Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Biopharmaceuticals for Psoriasis Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Biopharmaceuticals for Psoriasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Biopharmaceuticals for Psoriasis Sales by Country (K Units), 2021–2026
 Table 32. Europe Biopharmaceuticals for Psoriasis Sales by Country (K Units), 2027–2032
 Table 33. Europe Biopharmaceuticals for Psoriasis Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Biopharmaceuticals for Psoriasis Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Biopharmaceuticals for Psoriasis Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Biopharmaceuticals for Psoriasis Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Biopharmaceuticals for Psoriasis Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Biopharmaceuticals for Psoriasis Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Biopharmaceuticals for Psoriasis Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Biopharmaceuticals for Psoriasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Biopharmaceuticals for Psoriasis Sales by Country (K Units), 2021–2026
 Table 42. Latin America Biopharmaceuticals for Psoriasis Sales by Country (K Units), 2027–2032
 Table 43. Latin America Biopharmaceuticals for Psoriasis Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Biopharmaceuticals for Psoriasis Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Biopharmaceuticals for Psoriasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Biopharmaceuticals for Psoriasis Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Biopharmaceuticals for Psoriasis Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Biopharmaceuticals for Psoriasis Sales (K Units) by Type (2021–2026)
 Table 51. Global Biopharmaceuticals for Psoriasis Sales (K Units) by Type (2027–2032)
 Table 52. Global Biopharmaceuticals for Psoriasis Sales Market Share by Type (2021–2026)
 Table 53. Global Biopharmaceuticals for Psoriasis Sales Market Share by Type (2027–2032)
 Table 54. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Type (2021–2026)
 Table 57. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Type (2027–2032)
 Table 58. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Biopharmaceuticals for Psoriasis Sales (K Units) by Application (2021–2026)
 Table 61. Global Biopharmaceuticals for Psoriasis Sales (K Units) by Application (2027–2032)
 Table 62. Global Biopharmaceuticals for Psoriasis Sales Market Share by Application (2021–2026)
 Table 63. Global Biopharmaceuticals for Psoriasis Sales Market Share by Application (2027–2032)
 Table 64. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Biopharmaceuticals for Psoriasis Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Application (2021–2026)
 Table 67. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Application (2027–2032)
 Table 68. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Application (2027–2032)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Amgen Biopharmaceuticals for Psoriasis Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Eli Lilly Biopharmaceuticals for Psoriasis Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Johnson & Johnson Biopharmaceuticals for Psoriasis Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Pfizer Biopharmaceuticals for Psoriasis Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. AbbVie Company Information
 Table 91. AbbVie Description and Business Overview
 Table 92. AbbVie Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. AbbVie Biopharmaceuticals for Psoriasis Product
 Table 94. AbbVie Recent Developments/Updates
 Table 95. Organon Company Information
 Table 96. Organon Description and Business Overview
 Table 97. Organon Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Organon Biopharmaceuticals for Psoriasis Product
 Table 99. Organon Recent Developments/Updates
 Table 100. UCB Company Information
 Table 101. UCB Description and Business Overview
 Table 102. UCB Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. UCB Biopharmaceuticals for Psoriasis Product
 Table 104. UCB Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Biopharmaceuticals for Psoriasis Distributors List
 Table 108. Biopharmaceuticals for Psoriasis Customers List
 Table 109. Biopharmaceuticals for Psoriasis Market Trends
 Table 110. Biopharmaceuticals for Psoriasis Market Drivers
 Table 111. Biopharmaceuticals for Psoriasis Market Challenges
 Table 112. Biopharmaceuticals for Psoriasis Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biopharmaceuticals for Psoriasis
 Figure 2. Global Biopharmaceuticals for Psoriasis Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Biopharmaceuticals for Psoriasis Market Share by Type: 2025 & 2032
 Figure 4. TNF-α Product Picture
 Figure 5. Interleukin-17 Product Picture
 Figure 6. Interleukin-23 Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Biopharmaceuticals for Psoriasis Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Biopharmaceuticals for Psoriasis Market Share by Application: 2025 & 2032
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Biopharmaceuticals for Psoriasis Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Biopharmaceuticals for Psoriasis Market Size (US$ Million), 2021–2032
 Figure 15. Global Biopharmaceuticals for Psoriasis Sales (K Units), 2021–2032
 Figure 16. Global Biopharmaceuticals for Psoriasis Average Price (US$/Unit), 2021–2032
 Figure 17. Biopharmaceuticals for Psoriasis Report Years Considered
 Figure 18. Biopharmaceuticals for Psoriasis Sales Share by Manufacturers in 2025
 Figure 19. Global Biopharmaceuticals for Psoriasis Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Biopharmaceuticals for Psoriasis Players: Market Share by Revenue in Biopharmaceuticals for Psoriasis in 2025
 Figure 21. Biopharmaceuticals for Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Biopharmaceuticals for Psoriasis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021–2032)
 Figure 24. North America Biopharmaceuticals for Psoriasis Revenue Market Share by Country (2021–2032)
 Figure 25. United States Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021–2032)
 Figure 28. Europe Biopharmaceuticals for Psoriasis Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Biopharmaceuticals for Psoriasis Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Biopharmaceuticals for Psoriasis Revenue Market Share by Region (2021–2032)
 Figure 36. China Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Biopharmaceuticals for Psoriasis Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Biopharmaceuticals for Psoriasis Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Biopharmaceuticals for Psoriasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Biopharmaceuticals for Psoriasis by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Biopharmaceuticals for Psoriasis by Type (2021–2032)
 Figure 56. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Biopharmaceuticals for Psoriasis by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Biopharmaceuticals for Psoriasis by Application (2021–2032)
 Figure 59. Global Biopharmaceuticals for Psoriasis Price (US$/Unit) by Application (2021–2032)
 Figure 60. Biopharmaceuticals for Psoriasis Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Plaque Psoriasis Treatment Medications Market Research Report 2024
Global Psoriasis Therapeutics Market Insights Forecast to 2030
Global Psoriasis Biosimilar Market Research Report 2024
Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2024
Global Anti inflammatory Skincare Ingredients Market Research Report 2025
Global Psoriatic Arthritis Therapeutics Drug Market Insights Forecast to 2030
Global Biologic Medications for Psoriasis Market Research Report 2024
Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Research Report 2024
Global Interleukin Inhibitors for Psoriasis Market Research Report 2024
Global Psoriasis Treatment Drugs Market Research Report 2025
Global Acne Therapeutics Market Research Report 2024
Global Psoriasis Biologics Drugs Market Research Report 2025
Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acne Skin Medication Market Research Report 2024
Global Monoclonal Antibodies for Plaque Psoriasis Market Research Report 2024
Global Vitiligo Therapeutics Market Research Report 2024
Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025
Global Skin Disease Treatment Market Insights Forecast to 2030
Global IL 17 Inhibitors for Psoriasis Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions